FdaApprovalPulse benchmark report

As of 2026-11-04, FdaApprovalPulse holds 1,969 public records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration). The largest group is Drug labeling or REMS supplement with 1,180 (60%). Computed from the live dataset and updated on every refresh.

Last updated 2026-11-04 · Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)

By location

GroupRecords
Unknown1,614
CA110
MN61
MA37
OR20
TX18
AZ18
IL9
MD9
TN8
PA7
FL6
WA6
WI5
MO5

By category

GroupRecords
Drug labeling or REMS supplement1,180
PMA supplement (device change)367
Generic drug approval (ANDA)196
Drug efficacy supplement (new indication or use)77
Drug manufacturing (CMC) supplement55
New drug application (NDA)41
PMA original approval (new class III device)24
Biologic license (BLA)17
Other drug supplement12

Records by month

MonthRecords
2026-05277
2026-06498
2026-07312
2026-08303
2026-09314
2026-10265

Search every FdaApprovalPulse record free Free weekly digest

Frequently asked questions

How many records does the FdaApprovalPulse benchmark cover?

1,969 public records from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration), as of 2026-11-04.

How often is it updated?

On every data refresh, automatically.

Can I cite it?

Yes: cite "Zalwin, FdaApprovalPulse benchmark report" with a link to this page.

Computed by Zalwin. Informational only. FdaApprovalPulse alternatives · All reports